HONG KONG, Aug. 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its investigational next-generation B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received clinical trial clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). The clearance allows initiation of...
SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- From voice calls to intelligent interaction, from music enjoyment to vlog creation, audio is no longer mere signal processing...
LISHUI, China, Aug. 5, 2026 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (Nasdaq: FAMI) today announced that the Company has signed an acquisition...
BEIJING, Aug. 5, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers...